ObsEva SA.

NASDAQ:OBSV   3:59:53 PM EDT
3.17
+0.01 (+0.32%)
4:09:18 PM EDT: $3.14 -0.03 (-0.95%)
Products

Obseva Submits New Drug Application To FDA For Linzagolix

Published: 09/15/2021 05:20 GMT
ObsEva SA. (OBSV) - Obseva Announces Submission of New Drug Application to U.S. FDA for Linzagolix for the Treatment of Uterine Fibroids.